Clinical Trial Update: A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain [Phase 3]

View source ↗

Summary

Retatrutide (LY3437943) is being studied in a Phase 3 trial for obesity or overweight with chronic low back pain, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain
• Obesity
• Overweight

Drugs mentioned

• Retatrutide (retatrutide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 3 | Status: RECRUITING